News

Four Horizon Europe COVID-19 call topics: deadline further postponed to 20 May

Published on | 5 years ago

Programmes
Research Infrastructures Health

Technical problems with the submission system continue to exsist for the topics

HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

HORIZON-HLTH-2021-CORONA-01-02 Cohorts united against COVID-19 variants of concern

HORIZON-INFRA-EMERGENCY-2021-01 FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases

HORIZON-INFRA-EMERGENCY-2021-02 Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics

For this reason, the deadline for submission is postponed from 11 May (as was previously communicated) to 20 May at 17:00.

Source: Funding and Tender Portal

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1946 articles available search in articles 

Testimonial

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.